R. E. Blount, J. A. Morris, R. E. Savage: Recovery of cytopathogenic agent from chimpanzees with coryza. In: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). Band92, Nr.3, Juli 1956, S.544–549, doi:10.3181/00379727-92-22538, PMID 13359460 (englisch).
Robert M. Chanock et al.: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. In: American Journal of Hygiene. Band66, Nr.3, November 1957, S.281–290, doi:10.1093/oxfordjournals.aje.a119901, PMID 13478578 (englisch).
Robert M. Chanock, L. Finberg: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. In: American Journal of Hygiene. Band66, Nr.3, November 1957, S.291–300, doi:10.1093/oxfordjournals.aje.a119902, PMID 13478579 (englisch).
Gaya K. Amarasinghe et al.: Taxonomy of the order Mononegavirales: update 2019. In: Archives of Virology. Band164, Nr.7, Juli 2019, S.1967–1980, doi:10.1007/s00705-019-04247-4, PMID 31089958, PMC 6641539 (freier Volltext) – (englisch).
W. Thompson, D. K. Shay, E. Weintraub, L. Brammer, N. Cox, L. Anderson, K. Fukuda: Mortality associated with influenza and respiratory syncytial virus in the United States. In: Journal of the American Medical Association. (JAMA) 2003, Band 289, Nr. 2, S. 179–186, doi:10.1001/jama.289.2.179.
Mingyao Sun et al.: Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis. In: JAMA network open. Band6, Nr.2, 1. Februar 2023, S.e230023, doi:10.1001/jamanetworkopen.2023.0023, PMID 36800182, PMC 9938429 (freier Volltext) – (englisch).
Pedro A. Piedra: Clinical experience with respiratory syncytial virus vaccines. In: The Pediatric Infectious Disease Journal. Band22, 2 Suppl, Februar 2003, S.S94–99, doi:10.1097/01.inf.0000053893.15894.ff, PMID 12671459 (englisch).
Anna A. Shtro et al.: Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State. In: Molecules (Basel, Switzerland). Band27, Nr.7, 31. März 2022, S.2263, doi:10.3390/molecules27072263, PMID 35408661, PMC 9000545 (freier Volltext) – (englisch).
R. E. Blount, J. A. Morris, R. E. Savage: Recovery of cytopathogenic agent from chimpanzees with coryza. In: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.). Band92, Nr.3, Juli 1956, S.544–549, doi:10.3181/00379727-92-22538, PMID 13359460 (englisch).
Robert M. Chanock et al.: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. In: American Journal of Hygiene. Band66, Nr.3, November 1957, S.281–290, doi:10.1093/oxfordjournals.aje.a119901, PMID 13478578 (englisch).
Robert M. Chanock, L. Finberg: Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). II. Epidemiologic aspects of infection in infants and young children. In: American Journal of Hygiene. Band66, Nr.3, November 1957, S.291–300, doi:10.1093/oxfordjournals.aje.a119902, PMID 13478579 (englisch).
Gaya K. Amarasinghe et al.: Taxonomy of the order Mononegavirales: update 2019. In: Archives of Virology. Band164, Nr.7, Juli 2019, S.1967–1980, doi:10.1007/s00705-019-04247-4, PMID 31089958, PMC 6641539 (freier Volltext) – (englisch).
K. Thorburn: Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection. In: Archives of Disease in Childhood. 2009, Band 94, Nr. 2, S. 99–103, PMID 18653625.
Mingyao Sun et al.: Monoclonal Antibody for the Prevention of Respiratory Syncytial Virus in Infants and Children: A Systematic Review and Network Meta-analysis. In: JAMA network open. Band6, Nr.2, 1. Februar 2023, S.e230023, doi:10.1001/jamanetworkopen.2023.0023, PMID 36800182, PMC 9938429 (freier Volltext) – (englisch).
Pedro A. Piedra: Clinical experience with respiratory syncytial virus vaccines. In: The Pediatric Infectious Disease Journal. Band22, 2 Suppl, Februar 2003, S.S94–99, doi:10.1097/01.inf.0000053893.15894.ff, PMID 12671459 (englisch).
Anna A. Shtro et al.: Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State. In: Molecules (Basel, Switzerland). Band27, Nr.7, 31. März 2022, S.2263, doi:10.3390/molecules27072263, PMID 35408661, PMC 9000545 (freier Volltext) – (englisch).